Company CVAbout Fischer Medical Ventures Ltd 
Fischer Medical Ventures Ltd
Small Cap
Commodity Chemicals
Fischer Medical Ventures Limited is emerging as a leading player in the trading of MRI systems. Headquartered in the Andhra Pradesh MedTech Zone (AMTZ) in Vishakhapatnam, India, Company is pioneering the development of advanced, affordable, and accessible medical diagnostic and imaging technologies, through its wholly owned subsidiary. In partnership with the wholly owned subsidiary, it has established a significant international footprint, operating across multiple continents and key markets.
Company Coordinates
Company Details
104 1st Fl Bhhind Poisar Depot, Raghuleela Mall Kandivali (W) Mumbai Maharashtra : 400067
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 64.85 Cr
Number of Shares
64.85 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-Sep-2025
64.85
64.85
583663923
1
Stock Split
25-Jan-2024
5.35
53.50
51000000
10
Preferential basis
29-Jun-2023
25
2.50
2328000
10
Preferential basis
27-Nov-2017
1.72
0.17
-3268000
10
Capital Reduction & Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 7 FIIs (5.57%)
Promoter with highest holding
Fmv Holdings Pte Ltd (51.16%)
Highest Public shareholder
Roopal Hitesh Kawa (2.74%)
Individual Investors Holdings
26.29%
Board of Directors
Management
Designation
Remuneration
Sejal Soni
Non Executive Director
0
Ashishkumar Dhakan
Independent Non Exe. Director
0
Krishna Kumar Omprakash Dubey
Independent Director
0
Jeena Dineshchandra Suthar
Independent Women Director
0
Dilip Suryakant Jha
Director & CFO
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Laboratory Chemicals
0.02
100.00%
Laboratory Chemicals
Stock DNARevenue and Profits:
Net Sales:
86 Cr
(Quarterly Results - Sep 2025)
Net Profit:
14 Cr
Commodity Chemicals
INR 3,010 Cr (Small Cap)
2,063.00
40
0.00%
-0.04
0.41%
8.43
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
